Skip to main content

Addressing CMV in Solid Organ Transplant Patients with CMV inSIGHT T Cell Immunity

These knowledgeable physicians share how they manage their solid organ transplant patients at risk for CMV by utilizing CMV inSIGHTâ„¢ T Cell immunity. These unique case studies will cover situations like neutropenia, low-level CMV, the importance of CD4 T Cells and more. Learn when they use CMV inSIGHT T Cell Immunity testing to evaluate CMV-specific cell mediated immunity, what they do with the information from the lab report, and the outcomes of their patients. Including a recording of the Live Q&A at the end of the original presentation.

In this webinar you will learn how the physicians utilize CMV inSIGHT in the following solid organ transplant cases:

  • Neutropenic patient
  • Low-level CMV DNAemia
  • Importance of CD4 T Cell Response
  • In instances of CMV Resistance
  • When belatacept is used for immunosuppression

Presented By:

Justin Rosenheck, DO
Assistant Professor of Internal Medicine at Ohio State University

Dr Kapil Kumar Saharia, MD, MPH
Chief, Solid Organ Transplant Infectious Disease at University of Maryland School of Medicine

Dr. Abhay Dhand, MD, FIDSA
Director of Transplant Infectious Disease at Westchester Medical Center


Back to top